{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:04:38Z","timestamp":1777421078154,"version":"3.51.4"},"reference-count":110,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To review pharmacology, available dosage forms, efficacy, and safety of cannabis and cannabinoids in cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>In PubMed (1965 to June 2020) the search was conducted using the search terms cannabidiol, cannabis, CBD, dronabinol, endocannabinoids, medical marijuana, nabiximols, nabilone, THC, and cancer. Abstracts from article bibliographies were reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection and Data Extraction:<\/jats:title>\n                    <jats:p>Relevant English-language studies conducted in humans evaluating cannabis and cannabinoids for cancer treatment or related symptoms were considered. Reference lists in relevant articles, package inserts, guidance documents, and addditional articles evaluating cannabis and cannabinoids were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>Cannabis and cannabinoid effectiveness can be attributed to active components delta-9-tetrahydrocannabinol and cannabidiol. Multiple dosage forms exist, each with different properties contributing to efficacy and safety differences. No data supports use as anticancer agents, and mixed efficacy results have been reported when used in cancer patients with nausea, pain, and anorexia. Inclusion of medicinal and synthetic products, small sample sizes, varying patient populations, and different dosage forms, doses, and drug combinations. These products are well tolerated, and adverse effects depend on the main active component.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance to Patient Care and Clinical Practice:<\/jats:title>\n                    <jats:p>Healthcare professionals need to identify appropriateness, monitor, and document use of cannabis and cannabinoids similar to other drug therapies as well as educate the patients\/ caregivers about potential benefits and risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Current evidence for use of medical cannabis and cannabinoids in cancer patients is weak. However, healthcare professionals are in an ideal role to monitor and educate patients using medical cannabis and cannabinoids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1060028020965224","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T03:30:44Z","timestamp":1602905444000},"page":"870-890","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":26,"title":["Use of Cannabis and Cannabinoids in Patients With Cancer"],"prefix":"10.1177","volume":"55","author":[{"given":"Lindsey","family":"Sawtelle","sequence":"first","affiliation":[{"name":"UConn School of Pharmacy, Storrs, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-0224","authenticated-orcid":false,"given":"Lisa M.","family":"Holle","sequence":"additional","affiliation":[{"name":"UConn School of Pharmacy, Storrs, CT, USA"},{"name":"UConn Health Neag Cancer Center, Farmington, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,10,17]]},"reference":[{"key":"bibr1-1060028020965224","first-page":"35","volume-title":"Cannabis in Medical Practice","volume":"1997","author":"Aldrich M"},{"key":"bibr2-1060028020965224","first-page":"37","volume-title":"Cannabis and Cannabinoids","volume":"2002","author":"Fankhauser M"},{"key":"bibr3-1060028020965224","first-page":"34","volume":"110","author":"Mikuriya TH.","year":"1969","journal-title":"Calif Med"},{"key":"bibr4-1060028020965224","first-page":"180","volume":"42","author":"Bridgman MB","year":"2017","journal-title":"P T"},{"key":"bibr5-1060028020965224","first-page":"543","volume-title":"Encyclopedia of Drug Policy","volume":"2011","author":"Cameron JM"},{"key":"bibr6-1060028020965224","unstructured":"Drug Enforcement Administration. Office of Diversion Control. Title 21 United States Code (USC) Controlled Substances Act. Subchapter I\u2014Control and enforcement. Part B\u2014Authority to control; standards of controlled substances. \u00a7812. Schedules of controlled substances. (b) Placement on schedules; findings required. (1) Schedule I. Accessed August 9, 2020. http:\/\/www.deadiversion.usdoj.gov\/21cfr\/21usc\/812.htm"},{"key":"bibr7-1060028020965224","author":"Marinol","year":"2017","journal-title":"Patheon Softegels, Inc;"},{"key":"bibr8-1060028020965224","unstructured":"National Conference of State Legislators. State medical marijuana laws: affirmative action overview. Accessed June 1, 2020. https:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx"},{"key":"bibr9-1060028020965224","unstructured":"Cannabis Business Times. Cannabis legalization world map. Published June 29, 2017. Accessed June 1, 2020. https:\/\/www.cannabisbusinesstimes.com\/article\/cannabis-legalization-world-map\/"},{"key":"bibr10-1060028020965224","unstructured":"National Center for Complementary and Integrative Health. Cannabis (marijuana) and cannabinoids: what you need to know. Accessed July 29, 2020. https:\/\/www.nccih.nih.gov\/health\/cannabis-marijuana-and-cannabinoids-what-you-need-to-know"},{"key":"bibr11-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-016-0530-0"},{"key":"bibr12-1060028020965224","unstructured":"Congress.gov. H.R.5485\u2014Hemp Farming Act of 2018. Accessed June 1, 2020. https:\/\/www.congress.gov\/bill\/115th-congress\/house-bill\/5485"},{"key":"bibr13-1060028020965224","unstructured":"National Institute on Drug Abuse. Marijuana as medicine DrugFacts. Accessed July 29, 2020. https:\/\/www.drugabuse.gov\/publications\/drugfacts\/marijuana-medicine"},{"key":"bibr14-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.0813"},{"key":"bibr15-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.1221"},{"key":"bibr16-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2018.05266"},{"key":"bibr17-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1561859."},{"key":"bibr18-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1159\/000337376."},{"key":"bibr19-1060028020965224","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102195"},{"key":"bibr20-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02066.x"},{"key":"bibr21-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg143"},{"key":"bibr22-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.108"},{"key":"bibr23-1060028020965224","doi-asserted-by":"publisher","DOI":"10.3389\/fpharm.2018.00482"},{"key":"bibr24-1060028020965224","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6105.1000S11-012"},{"key":"bibr25-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.plantsci.2019.03.022"},{"key":"bibr26-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.5b00949"},{"key":"bibr27-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26826"},{"key":"bibr28-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.181"},{"key":"bibr29-1060028020965224","unstructured":"US Food and Drug Administration. Consumer updates. Vaping illness update: FDA warns public to stop using tetrahydrocannabinol (THC)-containing vaping products and any vaping products obtained off the street. Published October 4, 2019. Accessed June 1, 2020. https:\/\/www.fda.gov\/consumers\/consumer-updates\/vaping-illness-update-fda-warns-public-stop-using-tetrahydrocannabinol-thc-containing-vaping"},{"key":"bibr30-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2014.05.013"},{"key":"bibr31-1060028020965224","author":"Cesamet","year":"2006","journal-title":"Valeant Pharmaceuticals Interna-tional;"},{"key":"bibr32-1060028020965224","author":"Epidiolex","year":"2020","journal-title":"Greenwich Biosciences;"},{"key":"bibr33-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.200790152."},{"key":"bibr34-1060028020965224","unstructured":"Sativex (nabiximols). Product monograph. Accessed June 1, 2020. https:\/\/www.bayer.ca\/omr\/online\/sativex-pm-en.pdf"},{"key":"bibr35-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11909"},{"key":"bibr36-1060028020965224","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9010014"},{"key":"bibr37-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.004"},{"key":"bibr38-1060028020965224","first-page":"35928","volume":"64","author":"Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-)-D9-(trans)-Tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III","year":"1999","journal-title":"Fed Regist"},{"key":"bibr39-1060028020965224","unstructured":"The White House President Barack Obama. Synthetic drugs (a.k.a. K2, spice, bath salts, etc). Accessed July 29, 2020. https:\/\/obamawhitehouse.archives.gov\/ondcp\/ondcp-fact-sheets\/synthetic-drugs-k2-spice-bath-salts#:~:text=They%20are%20labeled%20%E2%80%9Cnot%20for,as%20a%20%E2%80%9Clegal%E2%80%9D%20high"},{"key":"bibr40-1060028020965224","unstructured":"Government of the District of Columbia Department of Public Health. An introduction to the biochemistry and pharmacology of medical cannabis. Accessed August 1, 2020. https:\/\/doh.dc.gov\/sites\/default\/files\/dc\/sites\/doh\/publication\/attachments\/Medical%20Cannabis%20An%20Introduction%20to%20the%20Biochemistry%20and%20Pharmacology.pdf"},{"key":"bibr41-1060028020965224","author":"Syndros","year":"2016","journal-title":"Inys Therapeutics;"},{"key":"bibr42-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13710"},{"key":"bibr43-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-3-291"},{"key":"bibr44-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0383"},{"key":"bibr45-1060028020965224","unstructured":"Government of Canada. Information for health care professionals: cannabis (marihuana, marijuana) and the cannabinoids. Accessed August 8, 2020. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/information-medical-practitioners\/information-health-care-professionals-cannabis-cannabinoids.html#a3.0"},{"key":"bibr46-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1300\/J175v04n01_03"},{"key":"bibr47-1060028020965224","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00130."},{"key":"bibr48-1060028020965224","unstructured":"Canadian Pharmacists Association. Cannabis for medical purposes: how to help patients find a safe and effective dose. Accessed August 8, 2020. https:\/\/www.pharmacists.ca\/cpha-ca\/assets\/File\/education-practice-resources\/Cannabis%20Dosing%20and%20Titrating%20Final_web.pdf"},{"key":"bibr49-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00057"},{"key":"bibr50-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00562"},{"key":"bibr51-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.2.567"},{"key":"bibr52-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq727"},{"key":"bibr53-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(91)90026-z"},{"key":"bibr54-1060028020965224","first-page":"219","volume":"64","author":"Steele N","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"bibr55-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/s0305-7372(82)80037-6"},{"key":"bibr56-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/s0305-7372(82)80032-7"},{"key":"bibr57-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/s0305-7372(82)80035-2"},{"key":"bibr58-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/s0305-7372(82)80036-4."},{"key":"bibr59-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/s0305-7372(82)80034-0"},{"key":"bibr60-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1983.247"},{"key":"bibr61-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198508000-0001"},{"key":"bibr62-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1007\/BF02934575"},{"key":"bibr63-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1136\/adc.61.5.502"},{"key":"bibr64-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1007\/bf01728184"},{"key":"bibr65-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1007\/bf00256701"},{"key":"bibr66-1060028020965224","first-page":"946","volume":"79","author":"Chan HS","year":"1987","journal-title":"Pediatrics"},{"key":"bibr67-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198508000-00013"},{"key":"bibr68-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90300-8"},{"key":"bibr69-1060028020965224","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-6-825"},{"key":"bibr70-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197906073002302"},{"key":"bibr71-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198001173020302"},{"key":"bibr72-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.06.008"},{"key":"bibr73-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsym-man.2012.07.014"},{"key":"bibr74-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.01.003"},{"key":"bibr75-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain-symman.2017.09.001"},{"key":"bibr76-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.02.018"},{"key":"bibr77-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1177\/2049463717710042"},{"key":"bibr78-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197510162931603"},{"key":"bibr79-1060028020965224","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-6-819"},{"key":"bibr80-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.140.11.1431"},{"key":"bibr81-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810401)47:7<1746::AID-CNCR2820470704>3.0.CO;2-4"},{"key":"bibr82-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820815)50:4<636::AID-CNCR2820500404>3.0.CO;2-4"},{"key":"bibr83-1060028020965224","first-page":"109","volume":"69","author":"Citron ML","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"bibr84-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1007\/bf00175407"},{"key":"bibr85-1060028020965224","first-page":"338","volume":"21","author":"Kluin-Neleman JC","year":"1979","journal-title":"Vet Hum Toxicol"},{"key":"bibr86-1060028020965224","first-page":"449","volume":"91","author":"Colls BM","year":"1980","journal-title":"N Z Med J"},{"key":"bibr87-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(82)80033-9"},{"key":"bibr88-1060028020965224","volume":"33","author":"Kleinman S","year":"1983","journal-title":"Curr Ther Res Clin Exp"},{"key":"bibr89-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951201)76:11<2330::AID-CNCR2820761122>3.0.CO;2-F"},{"key":"bibr90-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1300\/J175v01n01_03"},{"key":"bibr91-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1185\/030079907x167525"},{"key":"bibr92-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1847"},{"key":"bibr93-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4154-9"},{"key":"bibr94-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1177\/0003489415612801"},{"key":"bibr95-1060028020965224","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Antiemesis. V2.2020. Accessed August 7, 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf"},{"key":"bibr96-1060028020965224","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain V1.2020. Accessed June 1, 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pain.pdf"},{"key":"bibr97-1060028020965224","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Palliative Care V1.2020. Accessed June 1, 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf"},{"key":"bibr98-1060028020965224","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0094"},{"key":"bibr99-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603236"},{"key":"bibr100-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.07.014"},{"key":"bibr101-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.08.014"},{"key":"bibr102-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.008680"},{"key":"bibr103-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.001562"},{"key":"bibr104-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.09.042"},{"key":"bibr105-1060028020965224","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00309."},{"key":"bibr106-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1016\/j.ptdy.2019.09.022"},{"key":"bibr107-1060028020965224","unstructured":"AlliantRx. Medical marijuana legislation and the pharmacist. Published March 14, 2019. Accessed June 1, 2020. https:\/\/www.alliantrx.com\/medical-marijuana-legislation-and-the-pharmacist\/"},{"key":"bibr108-1060028020965224","unstructured":"Connecticut State Department of Consumer Protection. Medical marijuana program. Accessed June 1, 2020. https:\/\/portal.ct.gov\/DCP\/Medical-Marijuana-Program\/Medical-Marijuana-Program"},{"key":"bibr109-1060028020965224","unstructured":"Medical Board of California. Guidelines for the recommendation of cannabis for medical purposes. Accessed June 1, 2020. https:\/\/www.mbc.ca.gov\/Download\/Publications\/guidelines-cannabis-recommendation.pdf"},{"key":"bibr110-1060028020965224","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219883912"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028020965224","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1060028020965224","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1060028020965224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:15:56Z","timestamp":1777374956000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1060028020965224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,17]]},"references-count":110,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1177\/1060028020965224"],"URL":"https:\/\/doi.org\/10.1177\/1060028020965224","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,17]]}}}